Bisoprolol IR Pellets Manufacturer in India

Bisoprolol IR Pellets – Pharmaceutical-Grade Immediate-Release Pellets

Bisoprolol IR Pellets are pharmaceutical-grade immediate-release multiparticulate pellets containing Bisoprolol Fumarate as the active ingredient. Bisoprolol Fumarate has CAS Number 104344-23-2, molecular formula (C₁₈H₃₁NO₄)₂·C₄H₄O₄, and molecular weight 766.97 g/mol. The current USP specification for Bisoprolol Fumarate is 97.5%–102.0%, calculated on the anhydrous basis.

The immediate-release pellet format is designed to provide rapid release of Bisoprolol after administration. The multiparticulate system can provide flexibility in capsule-filling and oral formulation development, with the final release characteristics determined by the pellet composition, active loading, particle size and excipient system.

Bisoprolol Fumarate is used in immediate-release solid oral formulations, and published pharmaceutical literature describes immediate-release Bisoprolol formulations with dissolution assessment at pH 1.2, 4.5 and 6.8.

Important: I could not verify a reliable universal commercial strength specifically for Bisoprolol IR Pellets. Therefore, an exact pellet loading should not be invented. The SDP strength should be entered from the current SDP product specification or COA.

Key Features

• Pharmaceutical-grade Bisoprolol IR Pellets
• Active ingredient: Bisoprolol Fumarate
• Immediate-release multiparticulate format
• Suitable for capsule-filling applications
• Suitable for oral multiparticulate formulation development
• Product-specific active loading
• Controlled pellet size and flow characteristics
• Product-specific dissolution profile
• Suitable for formulation development and bulk pharmaceutical supply

Applications

Immediate-Release Oral Formulations

Bisoprolol IR Pellets are designed for immediate-release oral formulations requiring rapid active-ingredient release.

Capsule Filling

The multiparticulate pellet format is suitable for incorporation into capsule dosage forms according to the required active loading and formulation specification.

Multiparticulate Formulation Development

The pellets can be used as a formulation intermediate for development and optimization of oral multiparticulate dosage forms.

Pharmaceutical Manufacturing

Bisoprolol IR Pellets can be incorporated into pharmaceutical manufacturing processes where a controlled pellet size, active loading and immediate-release profile are required.

Bulk Pharmaceutical Supply

The pellets can be supplied in bulk according to the approved active loading and finished-product quality specification.

Why Bisoprolol IR Pellets from Swapnroop?

• Pharmaceutical-Grade Pellets – Designed for pharmaceutical formulation applications.
• Immediate-Release Format – Designed for rapid release of Bisoprolol Fumarate.
• Product-Specific Active Loading – Bisoprolol Fumarate loading is controlled according to the applicable product specification.
• Multiparticulate Format – Suitable for capsule filling and oral multiparticulate formulations.
• Controlled Pellet Characteristics – Pellet size, moisture, assay and dissolution can be controlled according to the approved specification.
• Formulation Flexibility – Suitable for immediate-release formulation development.
• Bulk Pharmaceutical Supply – Suitable for pharmaceutical manufacturers requiring bulk pellet intermediates.
• Bisoprolol Pellet Supplier Support – Product and supply parameters can be aligned with customer formulation requirements.

Get Bulk Quote via WhatsApp